BMS-813160
Names
Biological Activity
[Description]:
BMS-813160 is the first dual CCR2/CCR5 antagonist to enter clinical development for cardiovascular.
[Related Catalog]:
[Target]
CCR2
CCR5
[References]
[Related Small Molecules]
Chemical & Physical Properties
[ Molecular Formula ]:
C25H40N8O2
[ Molecular Weight ]:
484.64
[ Storage condition ]:
2-8℃